Articles From: NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health's DermACELL Tissue Products to CB Pharma Acquisition Corp. Announces Exercise of Portion of Over-Allotment Option in Conjunction With Its IPO


2014/12/9
TORONTO, Dec.
Sign-up for NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health's DermACELL Tissue Products investment picks
2014/12/18
Compugen Ltd.
Sign-up for Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University investment picks
2014/12/11
NEWTON, Mass., Dec.
Sign-up for Karyopharm Initiates Third Registration-Directed Clinical Trial of Oral Selinexor (KPT-330) investment picks
2015/1/21
Drive to remove income and employment stipulations on dealer approvals accelerating rapid market adoption for Equifax data amongst largest auto lenders SAN FRANCISCO , Jan.
Sign-up for Majority of Leading Auto Lenders Now Leveraging Unique Income and Employment Information through Equifax investment picks
2014/12/19
PHILADELPHIA , Dec.
Sign-up for Aberdeen Indonesia Fund, Inc. Announces Dividend investment picks
2014/12/2
HOUSTON , Dec.
Sign-up for Southwestern Energy Expands Northeast Marcellus Acreage Position And Firm Transportation Portfolio investment picks
2015/1/13
Axalta Coating Systems (NYSE: AXTA), a leading global manufacturer of liquid and powder coatings, is celebrating the North American International Auto Show in style.
Sign-up for Axalta Coating Systems North America Sponsors Detroit Fashion Week During Auto Show’s MAIN Event 2015 investment picks
2015/1/14
Sarepta Therapeutics Inc. (NASDAQ: SRPT), a developer of RNA-based therapeutics, today announced that it has initiated dosing of SRP-4053 in its first human trial, a Phase I/II study in Duchenne muscular dystrophy (DMD). This multiple-dose study will assess the safety, tolerability, efficacy, and pharmacokinetics of SRP-4053 in DMD patients with genotypes amenable to exon-53 skipping.
Sign-up for Sarepta Therapeutics Announces First Patient Dosed in European Phase I/II Study of SRP-4053 in Duchenne Muscular Dystrophy Patients investment picks
2015/1/26
Teva Pharmaceutical Industries (TEVA) said on Monday that the U.S. Food and Drug Administration approved its generic equivalent to AstraZeneca's (AZN) blockbuster heartburn treatment Nexium.
Sign-up for Teva's generic version of AstraZeneca's Nexium gets FDA approval investment picks
2015/2/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177098&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Pegasystems to Present at the Morgan Stanley Technology, Media & Telecom Conference investment picks
2014/12/23
Family Dollar Stores, Inc. (“Family Dollar” or the “Company”) (NYSE:FDO), a leading national discount retailer offering name brands and quality, private brand merchandise, today made the following announcement regarding the Special Meeting of Stockholders to vote on its proposed merger with Dollar Tree, Inc. (NASDAQ: DLTR), which was convened at 10:00 a.m. local time.
Sign-up for Family Dollar Adjourns Special Meeting of Stockholders to January 22, 2015 investment picks
2015/1/15
BILLINGS, Mont., Jan.
Sign-up for Stillwater Mining Company to Participate in the CIBC Institutional Investor Conference investment picks
2014/12/18
Aruba Networks, Inc. (NASDAQ:ARUN) today announced that in Gartner Inc.’s latest “ Magic Quadrant for Network Access Control ” report, Aruba and its ClearPass Access Management System have been positioned in the leaders quadrant.
Sign-up for Aruba Networks Positioned in Leaders Quadrant of Gartner’s Magic Quadrant for Network Access Control for Second Consecutive Year investment picks
2014/12/23
By Anora Mahmudova and Sara Sjolin, MarketWatch Economy grew at 5% annual pace in third quarter NEW YORK (MarketWatch) -- U.S. stocks continued their record run on Tuesday, as the Dow industrials shot past the 18,000 level for the first time while the S&P 500 hit an intraday record.
Sign-up for UPDATE: Dow industrials top 18,000 for first time; S&P 500 at record investment picks
2015/1/16
Leucadia National Corp.
Sign-up for Leucadia to provide FXCM with $300 million loan investment picks
2014/12/18
CHICAGO , Dec.
Sign-up for Aviv REIT Announces Closing Of $305 Million Acquisition investment picks
2014/12/3
Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”), will host its investor day in New York City, New York on Monday, December 8, 2014 at 2:00 p.m. Eastern Time.
Sign-up for Southcross Energy Partners, L.P. to Host Investor Day investment picks
2015/2/2
ITASCA, Ill.
Sign-up for Arthur J. Gallagher & Co. Acquires Aequus Trade Credit LLC investment picks
2014/12/30
NEW YORK , Dec.
Sign-up for American Realty Capital Healthcare Trust Announces Common Stock Distribution for January 2015 investment picks
2015/2/12
By John Letzing ZURICH--Swiss bank Credit Suisse Group AG said Thursday that it swung to a 921 million Swiss francs ($990.82 million) profit in the fourth quarter from a year-earlier loss reported at 476 million francs.
Sign-up for Credit Suisse Returns to Profit investment picks
2014/12/2
Improving job market for professionals creates pressure points for companies NEW YORK , Dec.
Sign-up for Record Level: America's Hiring Managers Optimistic on 2015 investment picks
2015/1/13
- Targeting REIT conversion as of January 1, 2016 - Continuing to pursue deleveraging strategy and prudent, sustainable development levels - Evaluating optimum operational structure and related efficiencies - Committed to core urban markets and office, retail and apartment asset classes CLEVELAND , Jan.
Sign-up for Forest City to convert to a REIT, continue to pursue strategic plan initiatives investment picks
2015/1/12
Ecolab introduces the Restora™ program for healthcare laundries.
Sign-up for Ecolab's Restora Program Removes Challenging Adhesives from Linen, Reducing Costs for Healthcare Laundries investment picks
2014/12/19
A.M. Best has affirmed the financial strength rating (FSR) of A (Excellent) and the issuer credit ratings (ICR) of “a” of the core U.S. life/health insurance subsidiaries of Unum Group (Unum) (headquartered in Chattanooga, TN)(NYSE:UNM). Concurrently, A.M. Best has affirmed the ICR of “bbb” of Unum, as well as all existing debt securities issued by the organization.
Sign-up for A.M. Best Affirms Ratings of Unum Group and Its Core U.S. Subsidiaries investment picks
2014/12/29
BURLINGTON, Mass., Dec.
Sign-up for CB Pharma Acquisition Corp. Announces Exercise of Portion of Over-Allotment Option in Conjunction With Its IPO investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: NOVADAQ Appointed Exclusive Worldwide Distributor of LifeNet Health's DermACELL Tissue Products to CB Pharma Acquisition Corp. Announces Exercise of Portion of Over-Allotment Option in Conjunction With Its IPO
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent